BMD 110 PREMIX 110GM/KG DIN 01988751
Status: Cancelled Post Market
Holder: A.L. LABORATORIES, INC.
Available to quote
Health Canada record
| Active ingredient(s) | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1992 |
| Current status date | 15-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BACITRACIN (BACITRACIN METHYLENE DISALICYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02408317 | BACITRACIN MD | BIO AGRI MIX LP | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Marketed |
| 02512866 | BACITRACIN MD SOLUBLE | BIO AGRI MIX LP | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Approved |
| 02206099 | BMD 110 G | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 110 G | Marketed |
| 02328135 | BMD SOLUBLE | PHIBRO ANIMAL HEALTH CORPORATION | Powder For Solution | BACITRACIN (BACITRACIN METHYLENE DISALICYLATE) 440 MG | Dormant |